BioCentury
ARTICLE | Product Development

TransCelerate looks to sustain momentum of data sharing post-pandemic

TransCelerate adds clinical trial conduct, real world data and pharmacovigilance agreement initiatives to its data sharing platform

October 30, 2020 12:02 AM UTC

TransCelerate hopes to continue broadening access to shared clinical trial data in the post-pandemic era, but whether it can do so depends on the willingness of its member companies to embed the COVID-driven collaborative philosophy for the long term.

Last week, the company unveiled three new initiatives that could help it build upon the momentum it’s generated during the COVID crisis...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article